MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway
Published: 13 November 2025| Version 2 | DOI: 10.17632/yyt6c95gcf.2
Contributor:
HENGYU RENDescription
Data of the article :MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway
Files
Categories
Breast Cancer, Cholesterol Metabolism